Ergomed
The Specialist, Study Start Up and Regulatory Affairs leads and coordinates all activities related to achieving site initiation readiness for complex clinical trials in rare disease and oncology. This role ensures regulatory compliance, manages study start-up documentation, and serves as a key liaison between internal teams, clients, and external stakeholders. The position involves developing regulatory strategies, negotiating clinical site agreements, and mitigating risks to protect timelines and data quality.
Ergomed Group is a global clinical development partner and contract research organization that helps biotech and pharmaceutical companies bring medicines to market. With a background in co‑development, it offers integrated services including clinical trial management, regulatory affairs, pharmacovigilance, medical affairs and patient recruitment across multiple therapeutic areas. Ergomed positions itself to accelerate development responsibly by combining scientific expertise with operational delivery and flexible partnership models for sponsors worldwide.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Ergomed.
Ergomed didn’t post a salary, so this is our estimate from similar listings.
5% above the average for this role
Specialist/Snr Specialist Study Start Up and Regulatory Affairs
ErgoMed, Inc.
Specialist/Snr Specialist Study Start Up and Regulatory Affairs
ErgoMed, Inc.
Specialist/Snr Specialist Study Start Up and Regulatory Affairs
ErgoMed, Inc.
Specialist/Snr Specialist Study Start Up and Regulatory Affairs
ErgoMed, Inc.
Specialist/Snr Specialist Study Start Up and Regulatory Affairs
ErgoMed, Inc.
Specialist/Snr Specialist Study Start Up and Regulatory Affairs
ErgoMed, Inc.